Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glycopyrronium vs Ondansetron for PONV
NCT05265507Phase 4Unknown
- Sponsor
- The 2nd Affiliated Hospital of Chongqing Medical University
- Start
- Mar 2022
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of glycopyrronium in postoperative nausea and vomiting (PONV), sponsored by The 2nd Affiliated Hospital of Chongqing Medical University. Status: unknown.
02
Drugs
glycopyrronium
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT05265507.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05265507.